Price Band
₹563 - ₹593
Lot Size
25
Issue Size
₹895 Cr
GMP
N/A
Subscription
93.71x
Analyzing...
IPO Schedule
1
Open
21 Nov 2025
2
Close
25 Nov 2025
3
Allotment
26 Nov 2025
4
Listing
28 Nov 2025
About Sudeep Pharma Ltd
Sudeep Pharma Ltd is a pharmaceutical company focused on manufacturing and marketing active pharmaceutical ingredients (APIs) and finished dosage formulations. They cater to both domestic and international markets, primarily focusing on niche therapeutic segments.
Key Strengths
- Established market presence and brand reputation in select therapeutic areas.
- Diversified product portfolio with a focus on specialized and complex APIs.
- Strong relationships with key customers and distributors.
- Experienced management team with a proven track record.
- Focus on research and development to introduce new products and improve existing formulations.
Risk Factors
- •Reliance on specific APIs and vulnerability to price fluctuations in raw materials.
- •Exposure to regulatory risks and compliance requirements in the pharmaceutical industry.
- •Competition from established players and new entrants in the API and formulation markets.
Valuation Analysis
The IPO is priced at a P/E of 47.61, which appears relatively high compared to some industry peers, potentially indicating a rich valuation. Investors should carefully consider the company's growth prospects and risk factors before investing.
IPO Details
ExchangeBSE
SegmentMAINBOARD
ISININE0QPI01025
NSE SymbolSUDEEPPHRM
Face Value₹1
Lot Size25
Issue Size₹895 Cr
Key Metrics
P/E Ratio47.61
Industry P/E25
EPS12.46
PAT Margin27.63%
Debt/Equity0.20
Growth & Quality
Revenue Growth (YoY)22.4%
ProfitableYes ✓
Anchor Investors58
Subscription
Total1.43x
Imbalance Ratio14.2x
Documents
Key Dates
Open Date21 Nov 2025
Close Date25 Nov 2025
Allotment26 Nov 2025
Listing28 Nov 2025